BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Sales Revenue by Similar Products (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Sep. 10, 2022	Sep. 11, 2021	Sep. 10, 2022	Sep. 11, 2021
Concentration Risk [Line Items]
Net sales and other revenue	$ 17,919.4	$ 16,505.7	$ 41,229.7	$ 37,775.1
Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 17,919.4	$ 16,505.7	$ 41,229.7	$ 37,775.1
Percentage of total net sales and other revenue	100.00%	100.00%	100.00%	100.00%
Non-perishables | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 9,004.5	$ 8,388.8	$ 20,450.5	$ 19,131.5
Percentage of total net sales and other revenue	50.30%	50.80%	49.60%	50.60%
Fresh | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 5,944.5	$ 5,679.3	$ 13,826.0	$ 13,091.8
Percentage of total net sales and other revenue	33.20%	34.40%	33.50%	34.70%
Pharmacy | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 1,476.3	$ 1,253.4	$ 3,399.8	$ 2,982.0
Percentage of total net sales and other revenue	8.20%	7.60%	8.30%	7.90%
Fuel | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 1,202.8	$ 918.5	$ 2,857.5	$ 1,967.8
Percentage of total net sales and other revenue	6.70%	5.60%	6.90%	5.20%
Other | Product Line | Product Concentration Risk
Concentration Risk [Line Items]
Net sales and other revenue	$ 291.3	$ 265.7	$ 695.9	$ 602.0
Percentage of total net sales and other revenue	1.60%	1.60%	1.70%	1.60%